| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
| 76 | 87 | 90 | 111 | 114 | |
Growth YoY Revenue Growth YoY% | 18.8 | 27.0 | 26.4 | ||
| 70 | 79 | 80 | 96 | 99 | |
| 6 | 9 | 10 | 15 | 15 | |
OPM OPM% | 7.4 | 9.9 | 10.9 | 13.4 | 12.7 |
| 0 | 1 | 2 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 2 |
PBT PBTCr | 6 | 9 | 11 | 15 | 15 |
| 1 | 2 | 3 | 3 | 3 | |
| 4 | 6 | 7 | 10 | 9 | |
Growth YoY PAT Growth YoY% | 91.1 | 63.6 | 26.7 | ||
NPM NPM% | 5.0 | 6.9 | 8.1 | 8.9 | 8.1 |
| 2.4 | 4.5 | 4.6 | 6.2 | 5.9 |
| Quarter | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
| 76 | 87 | 90 | 111 | 114 | |
Growth YoY Revenue Growth YoY% | 18.8 | 27.0 | 26.4 | ||
| 70 | 79 | 80 | 96 | 99 | |
| 6 | 9 | 10 | 15 | 15 | |
OPM OPM% | 7.4 | 9.9 | 10.9 | 13.4 | 12.7 |
| 0 | 1 | 2 | 1 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 2 |
PBT PBTCr | 6 | 9 | 11 | 15 | 15 |
| 1 | 2 | 3 | 3 | 3 | |
| 4 | 6 | 7 | 10 | 9 | |
Growth YoY PAT Growth YoY% | 91.1 | 63.6 | 26.7 | ||
NPM NPM% | 5.0 | 6.9 | 8.1 | 8.9 | 8.1 |
| 2.4 | 4.5 | 4.6 | 6.2 | 5.9 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 163 | 201 | 224 |
Growth Revenue Growth% | 23.2 | 26.7 | |
| 149 | 176 | 195 | |
| 14 | 25 | 29 | |
OPM OPM% | 8.7 | 12.3 | 13.1 |
| 1 | 2 | 1 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 0 |
Depreciation DepreciationCr | 1 | 3 | 4 |
PBT PBTCr | 13 | 23 | 30 |
| 3 | 6 | 7 | |
PAT PATCr | 10 | 17 | 19 |
Growth PAT Growth% | 74.2 | 43.3 | |
NPM NPM% | 6.0 | 8.5 | 8.5 |
| 7.4 | 10.9 | 12.1 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 163 | 201 | 224 |
Growth Revenue Growth% | 23.2 | 26.7 | |
| 149 | 176 | 195 | |
| 14 | 25 | 29 | |
OPM OPM% | 8.7 | 12.3 | 13.1 |
| 1 | 2 | 1 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 0 |
Depreciation DepreciationCr | 1 | 3 | 4 |
PBT PBTCr | 13 | 23 | 30 |
| 3 | 6 | 7 | |
PAT PATCr | 10 | 17 | 19 |
Growth PAT Growth% | 74.2 | 43.3 | |
NPM NPM% | 6.0 | 8.5 | 8.5 |
| 7.4 | 10.9 | 12.1 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 |
Reserves ReservesCr | 36 | 52 | 60 |
| 11 | 16 | ||
| 2 | 2 | ||
| 65 | 85 | 103 | |
| 56 | 69 | ||
| 9 | 15 | ||
| 65 | 85 | 103 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 |
Reserves ReservesCr | 36 | 52 | 60 |
| 11 | 16 | ||
| 2 | 2 | ||
| 65 | 85 | 103 | |
| 56 | 69 | ||
| 9 | 15 | ||
| 65 | 85 | 103 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| -5 | 0 | |
| 0 | -9 | |
| 34 | -1 | |
Net Cash Flow Net Cash FlowCr | 28 | -9 |
Free Cash Flow Free Cash FlowCr | -10 | -7 |
CFO To PAT CFO To PAT% | -51.6 | 2.8 |
CFO To EBITDA CFO To EBITDA% | -35.6 | 1.9 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| -5 | 0 | |
| 0 | -9 | |
| 34 | -1 | |
Net Cash Flow Net Cash FlowCr | 28 | -9 |
Free Cash Flow Free Cash FlowCr | -10 | -7 |
CFO To PAT CFO To PAT% | -51.6 | 2.8 |
CFO To EBITDA CFO To EBITDA% | -35.6 | 1.9 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 239 | 237 | 237 |
Price To Earnings Price To Earnings | 24.4 | 13.8 | 12.4 |
Price To Sales Price To Sales | 1.5 | 1.2 | 1.1 |
Price To Book Price To Book | 4.7 | 3.5 | 3.5 |
EV To EBITDA EV To EBITDA | 15.1 | 8.8 | 7.4 |
GPM GPM% | 92.6 | 91.2 | 91.2 |
OPM OPM% | 8.7 | 12.3 | 13.1 |
NPM NPM% | 6.0 | 8.5 | 8.5 |
ROCE ROCE% | 23.8 | 33.9 | 39.2 |
ROE ROE% | 19.1 | 25.3 | 25.3 |
ROA ROA% | 15.1 | 20.2 | 18.4 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 239 | 237 | 237 |
Price To Earnings Price To Earnings | 24.4 | 13.8 | 12.4 |
Price To Sales Price To Sales | 1.5 | 1.2 | 1.1 |
Price To Book Price To Book | 4.7 | 3.5 | 3.5 |
EV To EBITDA EV To EBITDA | 15.1 | 8.8 | 7.4 |
GPM GPM% | 92.6 | 91.2 | 91.2 |
OPM OPM% | 8.7 | 12.3 | 13.1 |
NPM NPM% | 6.0 | 8.5 | 8.5 |
ROCE ROCE% | 23.8 | 33.9 | 39.2 |
ROE ROE% | 19.1 | 25.3 | 25.3 |
ROA ROA% | 15.1 | 20.2 | 18.4 |
| Market CapitalizationMkt CapCr | 402 | 338 | 243 | 237 | 233 | 233 | 232 |
| Close PriceClose₹ | 285.90 | 93.41 | 680.10 | 150.00 | 38.16 | 404.00 | 320.00 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 32.16 | 11.11 | 12.40 | 20.45 | 28.93 | ||
| Price To SalesPS | 1.91 | 2.32 | 2.13 | 1.06 | 5.75 | 2.29 | 4.73 |
| RevenueRevenueCr | 210 | 145 | 114 | 224 | 41 | 101 | 49 |
| Revenue Growth TTMRev Gr TTM% | 27.5% | 6.1% | 28.2% | 26.7% | -8.4% | 41.8% | 96.6% |
| PAT Growth TTMPAT Gr TTM% | 41.9% | -294.4% | 26.1% | 43.3% | -238.4% | 16.6% | 83.2% |
| Market CapitalizationMkt CapCr | 402 | 338 | 243 | 237 | 233 | 233 | 232 |
| Close PriceClose₹ | 285.90 | 93.41 | 680.10 | 150.00 | 38.16 | 404.00 | 320.00 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 32.16 | 11.11 | 12.40 | 20.45 | 28.93 | ||
| Price To SalesPS | 1.91 | 2.32 | 2.13 | 1.06 | 5.75 | 2.29 | 4.73 |
| RevenueRevenueCr | 210 | 145 | 114 | 224 | 41 | 101 | 49 |
| Revenue Growth TTMRev Gr TTM% | 27.5% | 6.1% | 28.2% | 26.7% | -8.4% | 41.8% | 96.6% |
| PAT Growth TTMPAT Gr TTM% | 41.9% | -294.4% | 26.1% | 43.3% | -238.4% | 16.6% | 83.2% |